In the past ten years, with the care and strong support of the school and government departments, and with the joint efforts of teachers and students in the whole hospital, the discipline construction of Pharmaceutical College has made rapid development. 20 12 the first-class discipline of traditional Chinese medicine was awarded as the key discipline in Guangdong province. The College of Pharmacy has entered the "985 Advantage Discipline Innovation Platform" of Jinan University's innovative drug research, and was approved to set up the Collaborative Innovation Center for Traditional Chinese Medicine and Natural Medicine 20 1 1. An innovative drug research platform with complete functions, good equipment and standardized management and a modern pharmaceutical teaching and experimental center have been basically established. At present, the College of Pharmacy undertakes the national 973 and 863 plans, the major national special projects of new drug creation, the national science and technology support in the 11th and 12th Five-Year Plans, the key projects of the National Science Fund for Distinguished Young Scholars, the joint fund of the National Natural Science Foundation of China and the Guangdong Provincial Government, the innovation team project of the Ministry of Education, the general and youth fund projects of the National Natural Science Foundation of China, the key science and technology projects of the Ministry of Education, the team project of the Guangdong Provincial Natural Science Foundation, and Guangdong Province. During the 11th Five-Year Plan period, the College of Pharmacy received 72 scientific research projects, including 67.98 million yuan in vertical funding, 0.5 million yuan in horizontal funding and 83.28 million yuan in scientific research funding. Published more than 400 SCI papers and more than 50 academic monographs; Apply for 54 invention patents at home and abroad, of which 36 are authorized; Won 8 scientific and technological achievement awards at or above the provincial and ministerial level, including 3 second prizes and 5 third prizes; There are 0/5 new drugs/kloc-under research, including one drug 1 one and five drugs 1 one, which have entered the second phase of clinical trials.